NCT06880289View on ClinicalTrials.gov

Chemo-Radiotherapy Boost Treatment Guided by Perfusion MRI on Hypoxic Zones in Head and Neck Cancer

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

91

Participants

Timeline

Start Date

September 16, 2020

Primary Completion Date

July 31, 2024

Study Completion Date

July 31, 2027

Conditions
Squamous Cell Tumors of the Head and Neck
Interventions
DRUG

Cisplatin IV on days 1, 22, 43, at a dose of 100 mg/m2

Chemoradiotherapy will be performed from day 1 to day 49 regardless of the arm.

Trial Locations (2)

00144

IRCSS Regina Elena, Roma

"Regina Elena National Cancer Institute", Rome

All Listed Sponsors
lead

Regina Elena Cancer Institute

OTHER